Atlas Trials

Taper Or Abrupt Steroid Stop: TOASSTtrial

Clinical trial NCT03153527 · RECRUITING

Trial details

NCT number
NCT03153527
Sponsor
University Hospital, Basel, Switzerland
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Inflammatory DisorderAutoimmune
Start date
2017-05-31
Primary completion
2027-06-01
Enrollment
530

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.